Metabonomics Research Progress on Liver Diseases
Metabolomics as the new omics technique develops after genomics, transcriptomics, and proteomics and has rapid development at present. Liver diseases are worldwide public health problems. In China, chronic hepatitis B and its secondary diseases are the common liver diseases. They can be diagnosed by...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2017/8467192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832550307210461184 |
|---|---|
| author | Mengqian Yu Ying Zhu Qingwei Cong Chunyan Wu |
| author_facet | Mengqian Yu Ying Zhu Qingwei Cong Chunyan Wu |
| author_sort | Mengqian Yu |
| collection | DOAJ |
| description | Metabolomics as the new omics technique develops after genomics, transcriptomics, and proteomics and has rapid development at present. Liver diseases are worldwide public health problems. In China, chronic hepatitis B and its secondary diseases are the common liver diseases. They can be diagnosed by the combination of history, virology, liver function, and medical imaging. However, some patients seldom have relevant physical examination, so the diagnosis may be delayed. Many other liver diseases, such as drug-induced liver injury (DILI), alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD), and autoimmune liver diseases, still do not have definite diagnostic markers; the diagnosis consists of history, medical imaging, and the relevant score. As a result, the clinical work becomes very complex. So it has broad prospects to explore the specific and sensitive biomarkers of liver diseases with metabolomics. In this paper, there are several summaries which are related to the current research progress and application of metabolomics on biomarkers of liver diseases. |
| format | Article |
| id | doaj-art-d81e1535a2224e61bcd18aabfa272987 |
| institution | Kabale University |
| issn | 2291-2789 2291-2797 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology and Hepatology |
| spelling | doaj-art-d81e1535a2224e61bcd18aabfa2729872025-02-03T06:07:15ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972017-01-01201710.1155/2017/84671928467192Metabonomics Research Progress on Liver DiseasesMengqian Yu0Ying Zhu1Qingwei Cong2Chunyan Wu3Department of Infectious Diseases, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, ChinaDepartment of Infectious Diseases, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, ChinaDepartment of Infectious Diseases, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, ChinaDepartment of Infectious Diseases, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, ChinaMetabolomics as the new omics technique develops after genomics, transcriptomics, and proteomics and has rapid development at present. Liver diseases are worldwide public health problems. In China, chronic hepatitis B and its secondary diseases are the common liver diseases. They can be diagnosed by the combination of history, virology, liver function, and medical imaging. However, some patients seldom have relevant physical examination, so the diagnosis may be delayed. Many other liver diseases, such as drug-induced liver injury (DILI), alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD), and autoimmune liver diseases, still do not have definite diagnostic markers; the diagnosis consists of history, medical imaging, and the relevant score. As a result, the clinical work becomes very complex. So it has broad prospects to explore the specific and sensitive biomarkers of liver diseases with metabolomics. In this paper, there are several summaries which are related to the current research progress and application of metabolomics on biomarkers of liver diseases.http://dx.doi.org/10.1155/2017/8467192 |
| spellingShingle | Mengqian Yu Ying Zhu Qingwei Cong Chunyan Wu Metabonomics Research Progress on Liver Diseases Canadian Journal of Gastroenterology and Hepatology |
| title | Metabonomics Research Progress on Liver Diseases |
| title_full | Metabonomics Research Progress on Liver Diseases |
| title_fullStr | Metabonomics Research Progress on Liver Diseases |
| title_full_unstemmed | Metabonomics Research Progress on Liver Diseases |
| title_short | Metabonomics Research Progress on Liver Diseases |
| title_sort | metabonomics research progress on liver diseases |
| url | http://dx.doi.org/10.1155/2017/8467192 |
| work_keys_str_mv | AT mengqianyu metabonomicsresearchprogressonliverdiseases AT yingzhu metabonomicsresearchprogressonliverdiseases AT qingweicong metabonomicsresearchprogressonliverdiseases AT chunyanwu metabonomicsresearchprogressonliverdiseases |